Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Acadia Pharmaceuticals (Nasdaq: ACAD) will participate in two upcoming investor conferences. The 10th Annual SVB Leerink Global Healthcare Conference features a fireside chat on February 26, 2021, at 10:40 a.m. ET. The Cowen 41st Annual Health Care Conference follows with a presentation on March 1, 2021, at 12:20 p.m. ET. Both events will be held virtually, and live webcasts will be available on Acadia's website, followed by archived recordings for about one month. Acadia specializes in neuroscience breakthroughs for conditions like Parkinson’s disease psychosis.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences:

10^th Annual SVB Leerink Global Healthcare Conference
Fireside Chat Presentation: Friday, February 26, 2021 at 10:40 a.m. Eastern Time

Cowen 41^st Annual Health Care Conference
Fireside Chat Presentation: Monday, March 1, 2021 at 12:20 p.m. Eastern Time

These conferences will be held virtually. Live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005241/en/

FAQ

When will Acadia Pharmaceuticals participate in the SVB Leerink Global Healthcare Conference?

Acadia Pharmaceuticals will participate in the SVB Leerink Global Healthcare Conference on February 26, 2021, at 10:40 a.m. Eastern Time.

What is the date of the Cowen Annual Health Care Conference for Acadia Pharmaceuticals?

The Cowen 41st Annual Health Care Conference presentation by Acadia Pharmaceuticals is scheduled for March 1, 2021, at 12:20 p.m. Eastern Time.

How can I access the presentations from Acadia Pharmaceuticals' investor conferences?

The live webcasts of Acadia Pharmaceuticals' presentations will be available on their website and archived for approximately one month.

What is Acadia Pharmaceuticals known for?

Acadia Pharmaceuticals is known for developing the only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis.